食品医薬品局と科学的優先事項
1Robert M. Califf is commissioner of the US Food and Drug Administration, Silver Spring, MD, USA.
まとめ
米国食品医薬品局 (FDA) は 生物医学エコシステムとの関係を再考しなければなりません これは科学の進歩を 効果的な健康対策に変換し 寿命の縮小を逆転させる上で 極めて重要です
科学分野:
- 公衆衛生
- 生物医学
- 規制科学
背景:
- アメリカは他の高所得国と比較して 寿命が短くなっています
- パンデミックや地政学的な紛争などの世界的な課題は公衆衛生に影響を及ぼします.
- 米国食品医薬品局 (FDA) は,医療介入において重要な役割を果たしています.
研究 の 目的:
- アメリカ人の平均寿命が 減っていることに 取り組むためです
- バイオメディカル・エコシステムにおける FDAの関係を再考することを提案します
- 科学的研究の成果を 医療介入に活用する
主な方法:
- このセクションでは,特定の実験方法ではなく,戦略的ビジョンを概説しています.
- バイオメディカル研究開発の分野における政策と関係構築に焦点を当てています.
- 適応的な規制の枠組みの必要性を強調しています.
主要な成果:
- FDAの戦略的転換を提案しました
- 協力の改善のための重要な分野を特定する.
- 予想される結果:健康への介入の加速化
結論:
- FDAの役割の再考は 期待寿命のマイナスの傾向を逆転させるのに不可欠です
- 生物医学エコシステムの翻訳能力の強化は優先事項です.
- 効果的な科学翻訳は 将来の公衆衛生の成功の鍵です
さらに関連する動画
関連する概念動画
Drug Regulation
1.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.7K
Drug Control Governance: Regulatory Bodies and Their Impact
231
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
231
Preclinical Development: Overview
4.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.7K
Clinical Trials: Overview
3.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.3K
Drug Discovery: Overview
8.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.5K
Factors Affecting Drug Response: Overview
2.1K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.1K


